Zelavespib
- Generic Name
- Zelavespib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C18H21IN6O2S
- CAS Number
- 873436-91-0
- Unique Ingredient Identifier
- 06IVK87M04
- Background
Zelavespib (PU-H71) has been used in trials studying the treatment of LYMPHOMA, Solid Tumors, Metastatic Solid Tumor, and Myeloproliferative Neoplasms (MPN).
- Associated Conditions
- -
- Associated Therapies
- -
A Study of Zelavespib (PU-H71) in Subjects With AP-MPN or BP-MPN
- First Posted Date
- 2022-11-10
- Last Posted Date
- 2022-11-10
- Lead Sponsor
- Samus Therapeutics, Inc.
- Registration Number
- NCT05612633
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath